Teladoc Health Releases 10-Q Report

By Tamara Parker • Friday, May 02 06:12 • Permanent Link

Teladoc Health, Inc. has recently released its 10-Q report, providing a detailed insight into its financial condition and results of operations. The company operates globally, offering virtual healthcare services through its Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment provides virtual medical services and enterprise telehealth solutions, while the BetterHelp segment operates an online counselling and therapy platform. Teladoc Health serves employers, health plans, hospitals, and individual members, aiming to make virtual care the first step in any healthcare journey.

In the 10-Q report, Teladoc Health highlighted several key factors affecting its performance. In the Integrated Care segment, the number of U.S. Integrated Care Members increased by 10.7 million, reaching 102.5 million at the end of March 2025. Chronic care program enrollment also saw a 3% increase, reaching 1.151 million at the same period. However, the average monthly revenue per U.S. Integrated Care Member decreased to $1.27 in the first quarter of 2025, compared to $1.38 in the same period in 2024.

In the BetterHelp segment, the number of paying users decreased by 4% to 0.397 million for the three months ended March 31, 2025, compared to 0.415 million for the same period in 2024. Teladoc Health also noted the seasonality of its business, with the Integrated Care segment experiencing a concentration of new client contracts effective at the start of each calendar year, while the BetterHelp segment typically reduces marketing activity during the fourth quarter.

The report also discussed the company's critical accounting estimates and policies, emphasizing the use of non-GAAP financial measures such as Adjusted EBITDA and free cash flow to enhance understanding of its financial performance. Teladoc Health highlighted that these measures are used for business planning purposes and in measuring its performance relative to competitors.

Following these announcements, the company's shares moved -2.8%, and are now trading at a price of $6.99. If you want to know more, read the company's complete 10-Q report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.